american heart association glp 1 2025 AHA Scientific Sessions GLP-1 receptor agonists and myocardial

This finding is particularly significant as it demonstrates that the cardiovascular benefits of GLP-1 agonists extend beyond their glucose-lowering effects to encompass direct cardiovascular protection in obesity

Even small molecular differences can influence the therapeutic performance of peptide drugs

For myocardial infarction, GLP-1RAs alleviate and repair MI via SIRT1/Parkin/mitophagy, insulin-like growth factor-1/2 and upregulating -estrogen receptor

We provide continuous support for nutrition, mindset, and exercise to keep you accountable and motivated

The brand claims transdermal delivery "to the bloodstream," but independent verification of bioavailability is not publicly available

Webster, MD, is Senior Fellow at the Center for U.S